Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission

Aiden Abidov1, Rory Hachamovitch, Alan Rozanski

  • 1Departments of Imaging (Division of Nuclear Medicine) and Medicine (Division of Cardiology), Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

Insights

Atrial fibrillation (AF) independently increases cardiac death risk in patients undergoing myocardial perfusion imaging. Even with mildly abnormal scans, AF patients face higher risks, suggesting closer monitoring or earlier intervention may be needed.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Cardiac Imaging

Background:

  • The prognostic impact of atrial fibrillation (AF) in patients undergoing myocardial perfusion single-photon emission computed tomography (MPS) is not well-established.
  • Understanding AF's role is crucial for risk stratification in cardiac patients.

Purpose of the Study:

  • To assess if the presence of atrial fibrillation (AF) offers additional prognostic information beyond myocardial perfusion imaging (MPI) for predicting cardiac death (CD).
  • To evaluate the incremental prognostic value of AF in patients undergoing MPS.

Main Methods:

  • A cohort of 16,048 patients undergoing MPS was followed for cardiac death (CD).
  • Cox proportional hazards models were used to analyze clinical and perfusion data, comparing patients with and without AF.
  • Multivariable analysis adjusted for established risk factors for CD.

Main Results:

  • Atrial fibrillation (AF) was a significant predictor of cardiac death (CD) across all MPS categories: normal, mildly abnormal, and severely abnormal.
  • AF patients exhibited worse survival rates (p = 0.001) even after adjusting for key predictors.
  • In patients with gated MPS, AF provided incremental prognostic value over clinical, nuclear variables, and left ventricular ejection fraction (p = 0.014).

Conclusions:

  • Atrial fibrillation (AF) independently elevates the risk of cardiac events, including cardiac death (CD), beyond perfusion and function data in MPS patients.
  • Patients with AF face a high risk of CD, even with minimally abnormal MPS results.
  • Further research is needed to determine if AF patients with mildly abnormal MPS warrant earlier cardiac catheterization referral.
Abstract